Drug Trial Radar · NCT07189065
A Study of Rocbrutinib in Participants With Relapse or Refractory Non-GCB Diffuse Large B-Cell Lymphoma
Last checked: Nov 19, 2026Latest source record: Dec 16, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
150
Planned (sponsor's estimate)
Start
Nov 27, 2025
Primary completion
Dec 31, 2027
Study completion Dec 31, 2028
Sponsor
- Lead sponsor
- Guangzhou Lupeng Pharmaceutical Company LTD.Industry
- Sponsor type
- Industry
- First posted
- Sep 23, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an open-label, randomized controlled, multicenter Phase II clinical study primarily evaluating the efficacy and safety of Rocbrutinib monotherapy compared to the investigator's choice of BR/R2 regimen in patients with non-GCB DLBCL.
Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL)
Interventions
RocbrutinibDrug
200mg qd PO. The treatment will continue until progressive disease, unacceptable toxicity, etc.
BendamustineDrug
Participants will receive a total of 6 cycles (a cycle being 28 days) 90 mg/m2 Bendamustine (IV infusion) on Days 1 and 2 of Cycles 1-6.
RituximabDrug
Participants will receive a total of 6 cycles (a cycle being 28 days) of 375 mg/m2 Rituximab (IV infusion) on Day 1 of each cycle.
LenalidomideDrug
20mg qd PO day 1-21
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Response RateTime frame: Up to 24 Months
Locations
41 sites in 1 country. Site status is shown where the registry gives one.
Anhui Cancer Hospital (West Branch of Anhui Provincial Hospital)
Hefei, Anhui, China · Not yet recruiting
Beijing Shijitan Hospital
Beijing, Beijing Municipality, China · Not yet recruiting
Beijing Tongren Hospital
Beijing, Beijing Municipality, China · Not yet recruiting
National Cancer Center/Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China · Recruiting
Peking University Third Hospital
Beijing, Beijing Municipality, China · Not yet recruiting
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China · Not yet recruiting
Fujian Cancer Hospital
Fuzhou, Fujian, China · Not yet recruiting
Affiliated Cancer Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China · Not yet recruiting
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China · Not yet recruiting
Nanfang Hospital
Guangzhou, Guangdong, China · Not yet recruiting
Meizhou People's Hospital
Meizhou, Guangdong, China · Not yet recruiting
Affiliated Tumor Hospital of Guangxi Medical University
Nanning, Guangxi, China · Not yet recruiting
The First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China · Not yet recruiting
The Fourth Hospital of Hebei Medical University
Shijiazhuang, Hebei, China · Not yet recruiting
The First Affiliated Hospital of Henan University of Science and Technology
Luoyang, Henan, China · Not yet recruiting
Henan Cancer Hospital
Zhengzhou, Henan, China · Recruiting
Henan Provincial People's Hospital
Zhengzhou, Henan, China · Not yet recruiting
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China · Not yet recruiting
Hubei Cancer Hospital
Wuhan, Hubei, China · Not yet recruiting
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China · Not yet recruiting
The First Affiliated Hospital of Xiamen University
Xiamen, Hujian, China · Not yet recruiting
Hunan Cancer Hospital
Changsha, Hunan, China · Not yet recruiting
The Second Xiangya Hospital of Central South University
Changsha, Hunan, China · Not yet recruiting
Jiangsu Cancer Hospital
Nanjing, Jiangsu, China · Not yet recruiting
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China · Not yet recruiting
The Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu, China · Not yet recruiting
Jiangxi Cancer Hospital
Nanchang, Jiangxi, China · Not yet recruiting
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China · Not yet recruiting
The First Hospital of Jilin University
Jilin City, Jilin, China · Not yet recruiting
The Second Affiliated Hospital of Dalian Medical University
Dalian, Liaoning, China · Not yet recruiting
Liaoning Cancer Hospital
Shenyang, Liaoning, China · Not yet recruiting
Shengjing Hospital of China Medical University
Shenyang, Liaoning, China · Not yet recruiting
Linyi Cancer Hospital
Linyi, Shandong, China · Not yet recruiting
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China · Not yet recruiting
Shanxi Bethune Hospital
Taiyuan, Shanxi, China · Not yet recruiting
Shanxi Province Cancer Hospital
Taiyuan, Shanxi, China · Not yet recruiting
Sichuan Cancer Hospital
Chengdu, Sichuan, China · Not yet recruiting
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
Tianjin, Tianjin Municipality, China · Not yet recruiting
The First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China · Not yet recruiting
The Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China · Not yet recruiting
Showing 40 of 41 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.